Skip to main content
. 2011 Dec 16;17(4):459–465. doi: 10.1177/159101991101700410

Figure 1.

Figure 1

Figure 1

Axial and sagittal T1 post-contrast MRI images prior to and during treatment with SIACI of bevacizumab and cetuximab. A,B) Pre-transclival surgical resection showing tumor burden. C,D) 1-month post-transclival surgical resection approximately 1-month before the first SIACI chemotherapy treatment. E,F) 1-month post first SIACI of chemotherapy treatment. G,H) 1-month post second SIACI of chemotherapy treatment showing stable disease.